title: The caBIG® Life Science Business Architecture Model.
abstract: BACKGROUND
  Business Architecture Models (BAMs) describe what a business does, who performs the activities, where and when activities are performed, how activities are accomplished and which data are present. The purpose of a BAM is to provide a common resource for understanding business functions and requirements and to guide software development. The cancer Biomedical Informatics Grid (caBIG®) Life Science BAM (LS BAM) provides a shared understanding of the vocabulary, goals and processes that are common in the business of LS research.
  
  
  RESULTS
  LS BAM 1.1 includes 90 goals and 61 people and groups within Use Case and Activity Unified Modeling Language (UML) Diagrams. Here we report on the model's current release, LS BAM 1.1, its utility and usage, and plans for future use and continuing development for future releases.
  
  
  METHODS
  The LS BAM is freely available as UML, PDF and HTML (https://wiki.nci.nih.gov/x/OFNyAQ).
authors: Department of Medicine, Hematology/Oncology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA. lbboyd@bcm.edu
authors: Lauren Becnel
authors: LB
authors: Boyd
authors: Scott P
authors: SP
authors: Hunicke-Smith
authors: Grace A
authors: GA
authors: Stafford
authors: Elaine T
authors: ET
authors: Freund
authors: Michele
authors: M
authors: Ehlman
authors: Uma
authors: U
authors: Chandran
authors: Robert
authors: R
authors: Dennis
authors: Anna T
authors: AT
authors: Fernandez
authors: Stephen
authors: S
authors: Goldstein
authors: David
authors: D
authors: Steffen
authors: Benjamin
authors: B
authors: Tycko
authors: Juli D
authors: JD
authors: Klemm
mesh_terms: D035843:Biomedical Research; D019295:Computational Biology / Q000379:methods; D003199:Computer Systems; D054547:National Cancer Institute (U.S.); D009369:Neoplasms / Q000188:drug therapy / Q000503:physiopathology; D012984:Software; D014481:United States; D018875:Vocabulary, Controlled